PHARMA TECH SUMMIT – ZURICH

What an inspiring time at the Pharma Tech Summit in Zurich! A big thank you to the organizers The People Events and Pharma Tech Summit and all the incredible participants for such a forward-thinking event. It was a pleasure to connect with so many brilliant minds pushing the boundaries of drug development and exploring how AI […]
BIO INTERNATIONAL 2025 – BOSTON

Innovation starts with connection. 🤝 We don’t innovate alone. At BioClonal, we believe breakthroughs happen one conversation at a time — and BIO International 2025 was proof of that. We’re grateful to have shared ideas, challenges and hopes with people who believe, like us, that science has the power to change lives. 🔬 We came […]
South Summit 2025

We are proud to have been represented at South Summit 2025 by our founder as part of the #TechFabLab, supported by Instituto Aragonés de Fomento. At BioClonal, we believe that biotechnology has the power not only to transform industries, but also to change lives. Events like #SouthSummit give us the chance to share our mission: […]
Bioclonal Receives the Innovative SME Seal

We have been awarded the Innovative SME Seal, a distinction granted by the Ministry of Science, Innovation and Universities of the Government of Spain, valid until April 14, 2028. This recognition certifies our capacity for innovation and our commitment to scientific research and technological development in the field of biotechnology. It serves as an endorsement […]
BioClonal drives innovative solutions against antimicrobial resistance

Antimicrobial resistance (AMR) remains one of the most pressing global health threats, jeopardizing both modern medicine and the achievement of the Sustainable Development Goals. Every year, millions of lives are affected by infections caused by resistant bacteria, and it is estimated that, without urgent action, AMR could cause up to 10 million deaths annually by […]
BioClonal oficially inaugurates its new facilities

BioClonal has officially inaugurated its cutting-edge laboratories in Zaragoza, Spain, marking a major milestone in its mission to combat Alzheimer’s disease. The event, attended by over 50 guests including Aragón’s regional president Jorge Azcón, showcased the company’s groundbreaking work in personalized monoclonal antibody research. CEO Paula Garfella highlighted BioClonal’s commitment to addressing complex medical challenges, […]
Jessika Valero receives de IMPULSA Award for Female Leadership

We are thrilled to announce that our Technical Director, Jessika Valero, has been honored with the prestigious IMPULSA Award for Female Leadership. This recognition celebrates exceptional female talent and leadership, acknowledging the drive, career achievements, and future potential of outstanding women in executive roles. Jessika shared this proud moment with fellow honoree Paloma Yarza, President […]
DESAFÍA BOSTON

BioClonal has been selected to represent Spanish biotechnology at the prestigious Desafía Boston program, organized by Richi Entrepreneurs and ICEX. This program offers participants a unique opportunity to expand their international presence and engage with Boston’s thriving biotech community.On October 1st, the first session took place in Madrid, where Pablo Caño delivered an inspiring workshop […]
Festival of Biologics 2024

BioClonal is thrilled to announce our participation in the Festival of Biologics 2024, one of the most significant events in the biotechnology industry. This is an excellent opportunity for us to connect with fellow innovators, researchers, and industry leaders. We warmly invite you to visit us at our stand, number S16, where our knowledgeable team […]
PEGS Europe 2024

BioClonal is thrilled to participate in PEGS Europe 2024, a premier event dedicated to the latest advancements in protein and antibody engineering. This conference provides an excellent platform for industry leaders, researchers, and innovators to come together, share insights, and explore collaboration opportunities. We invite you to join us for engaging discussions about our pioneering […]